3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Breast Neoplasms
23
Neoplasm Metastasis
14
Glioma
14
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
12
Lung Neoplasms
11
Glioblastoma
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Medulloblastoma
8
Ovarian Neoplasms
7
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Carcinoma, Hepatocellular
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Osteosarcoma
6
Melanoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Interventions
AZD 6244
3
mirdametinib
2
Sirolimus
2
Inhalation
2
Everolimus
2
Acetylcysteine
2
trametinib
1
tipifarnib
1
pirfenidone
1
peginterferon alfa-2b
1
omipalisib
1
cediranib
1
binimetinib
1
Vincristine
1
Vinblastine
1
Temozolomide
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy
1
N-monoacetylcystine
1
Methotrexate
1
Magnetic Resonance Imaging
1
Lovastatin
1
Lenalidomide
1
Ifosfamide
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Etoposide
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibromatosis 1
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.